PROTAGENIC
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Dec 2030: the §8 declaration of use).
Record
- Serial number
- 97160442
- Registration number
- 7589137
- Mark type
- Word mark
- Filed
- 07 Dec 2021
- Published for opposition
- 21 Mar 2023
- Registered
- 03 Dec 2024
- Next maintenance filing
- §8 declaration of use, due by 03 Dec 2030 (grace period to 03 Jun 2031)
- Attorney of record
- Erik M. Pelton
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of stress, PTSD, depression, anxiety, addiction, addiction withdrawal symptoms, brain functions, neuropsychiatric disorders, and neurodegenerative diseases
Owner
- Protagenic Therapeutics, Inc., New York, NY, US
- Protagenic Therapeutics, Inc., New York, NY, US
- Protagenic Therapeutics, Inc., New York, NY, US
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Feb 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 13 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jan 2024 — USE AMENDMENT FILED
- 10 Feb 2024 — SOU EXTENSION 1 GRANTED
- 16 Nov 2023 — SOU EXTENSION 1 FILED
- 10 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Jan 2024 — NOTICE OF REVIVAL - E-MAILED
- 22 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 22 Jan 2024 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 22 Jan 2024 — NOTICE OF REVIVAL - E-MAILED